Australian Women's Perspectives on Preventing Postpartum Relapse or Quitting Smoking or Vaping in the Postpartum Year
Abstract
Introduction: High postpartum smoking relapse rates indicate opportunities to address nicotine dependence. Data on postpartum vaping are scarce. This study explored postpartum women's perspectives on support for quitting or preventing relapse to smoking and vaping.
Methods: Postpartum women who smoked or quit during pregnancy completed brief telephone interviews at 2, 4, 6, and 12 months postpartum (May 2023-December 2024). Interviews included the question: In the ideal world, what support would you need to help you stop smoking or vaping or stay quit? Inductive content analysis was conducted. Responses were examined by timepoint and by four smoking/vaping status groups (quit nicotine products during pregnancy [QPreg]; quit postpartum [QPP]; never quit [NQ]; relapsed postpartum [R]) was explored.
Results: Of 832 invited, 770 (93%) consented, 566 (74%) completed at least one interview. The proportion in each group was consistent across timepoints: QPreg (21%-23%; n = 53-111), QPP (9%-11%; n = 25-47), NQ (56%-57%; n = 140-284), and R (10%-14%; n = 34-57). Also consistent across time were smoking prevalence (59%-61%), vaping prevalence (7%-8%), and dual use with combustible tobacco (7%-9%). Six main categories: I don't know/nothing; Health professional support; Physical health; Mental-emotional health; Social-environmental health; Public health, and 22 generic categories were interpreted. Coding patterns were generally consistent across timepoints, with some subgroup…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.